Be Bio raises $82m to advance haemophilia B gene therapy to Phase I/II trial
There are already two FDA-approved gene therapies for haemophilia B courtesy of Pfizer and CSL Behring.
There are already two FDA-approved gene therapies for haemophilia B courtesy of Pfizer and CSL Behring.
What's Your Reaction?
